test44
https://www.cytel.com/blog/cytel-at-ispor-europe-a-top-presenter
October 13, 2022
ISPOR Europe, the leading global conference for health economics and outcomes research (HEOR) and real-world evidence..
Read article
test44
https://www.cytel.com/blog/interview-with-josh-schultz
October 11, 2022
On the occasion of Cytel’s 35th anniversary, our CEO Joshua Schultz sits down with Dr. Esha Senchaudhuri to discuss the..
Read article
test44
https://www.cytel.com/blog/platform-trials-can-they-benefit-animal-studies
October 5, 2022
Master protocols and platform clinical trials have become an innovative and efficient approach to testing multiple..
Read article
test44
https://www.cytel.com/blog/mcmc-vs.-inla-in-bayesian-adaptive-clinical-trial-designs
October 4, 2022
Integrated Nested Laplacian Approximations (or INLA) are now starting to be used by statisticians as a key tool for..
Read article
test44
https://www.cytel.com/blog/bayesian-methods-for-historical-borrowing-conjugate-priors
October 3, 2022
The wider availability of electronic health data, medical registries, and even larger proprietary datasets means that..
Read article
test44
https://www.cytel.com/blog/industry-voices-a-conversation-with-albert-kim-on-simulation-guided-design
test44
https://www.cytel.com/blog/statistical-leaders-and-the-future-of-drug-development
September 28, 2022
The landscape of drug development has changed dramatically over the last few decades, and effective statistical leaders..
Read article
test44
https://www.cytel.com/blog/data-capture-and-data-sharing-during-the-covid-19-pandemic
September 27, 2022
On Louis Dron et al., “Data Capture and Sharing in the COVID-19 Pandemic: A Cause for Concern,” The Lancet 4 (10) (2022)
Read article
test44
https://www.cytel.com/blog/adaptive-trials-at-the-mainstream-of-drug-development
September 23, 2022
Adaptive trial designs – that is, trials that include a prospectively planned modification based on an interim analysis..
Read article
